KANK1 | KN motif and ankyrin repeat domains 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
DMRT1 | Doublesex and mab-3 related transcription factor 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
KIAA0020 | KIAA0020 | | | | | | Expressed in all |
RFX3 | Regulatory factor X, 3 (influences HLA class II expression) | Transcription factors
| | | | | Tissue enhanced |
GLIS3 | GLIS family zinc finger 3 | Disease related genes Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
SPATA6L | Spermatogenesis associated 6-like | | | | | | Tissue enhanced |
INSL6 | Insulin-like 6 | Predicted secreted proteins
| | | | | Tissue enriched |
PLGRKT | Plasminogen receptor, C-terminal lysine transmembrane protein | Mitochondrial proteins
| | | | | Expressed in all |
KIAA1432 | KIAA1432 | Predicted membrane proteins
| | | | | Expressed in all |
MLANA | Melan-A | Predicted membrane proteins
| | | | | Tissue enriched |
RANBP6 | RAN binding protein 6 | | | | | | Expressed in all |
IL33 | Interleukin 33 | | | | | | Mixed |
UHRF2 | Ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase | Disease related genes
| | | | | Expressed in all |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
TYRP1 | Tyrosinase-related protein 1 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
LURAP1L | Leucine rich adaptor protein 1-like | | | | | | Mixed |
NFIB | Nuclear factor I/B | Cancer-related genes Transcription factors
| | | | | Mixed |
SNAPC3 | Small nuclear RNA activating complex, polypeptide 3, 50kDa | Plasma proteins
| | | | | Expressed in all |
PSIP1 | PC4 and SFRS1 interacting protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BNC2 | Basonuclin 2 | Transcription factors
| | | | | Tissue enhanced |
SH3GL2 | SH3-domain GRB2-like 2 | | | | | | Tissue enriched |
RRAGA | Ras-related GTP binding A | | | | | | Expressed in all |
HAUS6 | HAUS augmin-like complex, subunit 6 | | | | | | Expressed in all |
PLIN2 | Perilipin 2 | Plasma proteins
| | | | | Expressed in all |
DENND4C | DENN/MADD domain containing 4C | Predicted membrane proteins
| | | | | Expressed in all |
RPS6 | Ribosomal protein S6 | Ribosomal proteins
| | | | | Expressed in all |
MLLT3 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MTAP | Methylthioadenosine phosphorylase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CDKN2B | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | | | | | | Mixed |
ELAVL2 | ELAV like neuron-specific RNA binding protein 2 | | | | | | Group enriched |
PLAA | Phospholipase A2-activating protein | Plasma proteins
| | | | | Expressed in all |
EQTN | Equatorin, sperm acrosome associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
C9orf72 | Chromosome 9 open reading frame 72 | Disease related genes
| | | | | Expressed in all |
ACO1 | Aconitase 1, soluble | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |
DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | Enzymes
| | | | | Expressed in all |
TOPORS | Topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase | Disease related genes
| | | | | Expressed in all |
NDUFB6 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
APTX | Aprataxin | Disease related genes
| | | | | Expressed in all |
DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 | | | | | | Expressed in all |
SMU1 | Smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) | | | | | | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted secreted proteins
| | | | | Group enriched |
BAG1 | BCL2-associated athanogene | Cancer-related genes
| | | | | Expressed in all |
CHMP5 | Charged multivesicular body protein 5 | Plasma proteins
| | | | | Expressed in all |
NFX1 | Nuclear transcription factor, X-box binding 1 | Plasma proteins Transcription factors
| | | | | Expressed in all |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NOL6 | Nucleolar protein 6 (RNA-associated) | Predicted membrane proteins
| | | | | Expressed in all |
PRSS3 | Protease, serine, 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |